A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.

Withdrawn before enrolling · Phase 4

Conditions studied: Anemia, Iron Deficiency

In brief

The purpose of this study is to establish which dosing schedule of INfed (Iron dextrose) is superior for the treatment of iron deficient anemia.

Key facts

Study ID

NCT03286205

Run by

Sutter Gould Medical Foundation

People needed

0

Starts

2015-04-14

Expected to finish

2018-08-31

Last updated by the study team

2019-06-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients over the age of 18 years old.
• Being treated by a Sutter Health Physician.
• Hemoglobin of < 10mg/dl for Men and Women
• Ferritin </= 10ng/ml
• Patients in whom oral administration is unsatisfactory or impossible.

You may not qualify if…

• Patients with a history of receiving iron or other hematinic in the preceding 3 months, oral iron is allowable.
• Anemia due to acute blood loss; menorrhagia is allowed.
• Patients with a current illness known to interact with iron status.
• Patients unwilling to consent to required blood draws.
• Patients who are viewed as unable to complete treatment, based on PI recommendation.

Where it is running

• Sutter Gould Medical Foundation — Modesto, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.